Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Medical Oncology|January 11, 2021
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumorsAnna Forsythe, Wei Zhang, Uwe Phillip Strauss, et al.
Cancer Management and Research|May 17, 2018
Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2- metastatic breast cancer?Anna Forsythe, David Chandiwana, Janina Barth, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 24, 2020
Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in FranceGabriel Tremblay, Clemence Cariou, Christian Recher, et al.
Future Oncology (London, England)|April 21, 2023
Real-world evidence in lung and hematologic oncology health technology appraisals: a review of six assessment agenciesSharada Harricharan, Eileen Curran, Huamao Mark Lin, et al.
American Journal of Therapeutics|February 15, 2011
Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapyEric Q Wu, Anna Forsythe, Annie Guérin, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 9, 2018
Systematic review of health state utility values for acute myeloid leukemiaAnna Forsythe, Patricia S Brandt, Mike Dolph, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trialsJasvinder A Singh, Shuo Yang, Vibeke Strand, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 20, 2022
Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)Mihaela Georgiana Musat, Christina Soeun Kwon, Elizabeth Masters, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 10, 2019
Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United StatesGabriel Tremblay, Qayyim Said, Anuja Nidumolu Roy, et al.
Advances in Therapy|December 5, 2024
Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature ReviewKhashayar Azimpour, Carla Tordoff-Gibson, Patricia Dorling, et al.
Pageof 5